Heparin-induced thrombocytopenia history and symptoms: Difference between revisions

Jump to navigation Jump to search
m (Changed protection level for "Heparin-induced thrombocytopenia history and symptoms" ([Edit=Allow only autoconfirmed users] (expires 14:30, 7 January 2014 (UTC)) [Move=Allow only autoconfirmed users] (expires 14:30, 7 January 2014 (UTC))))
mNo edit summary
Line 39: Line 39:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Drugs]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Up-To-Date]]


{{WS}}
{{WH}}
{{WH}}
{{WS}}

Revision as of 19:42, 17 June 2016

Heparin-induced thrombocytopenia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Heparin-induced thrombocytopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Heparin-induced thrombocytopenia history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heparin-induced thrombocytopenia history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Heparin-induced thrombocytopenia history and symptoms

CDC on Heparin-induced thrombocytopenia history and symptoms

Heparin-induced thrombocytopenia history and symptoms in the news

Blogs on Heparin-induced thrombocytopenia history and symptoms

Directions to Hospitals Treating Heparin-induced thrombocytopenia

Risk calculators and risk factors for Heparin-induced thrombocytopenia history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]

Overview

Heparin-induced thrombocytopenia is diagnosed when the platelet count falls by > 50% typically after 5-10 days of heparin therapy. It is a clinicopathologic diagnosis and early diagnosis and management may be life saving. Unlike other immune mediated thrombocytopenia (idiopathic thrombocytopenic purpura), the levels of platelet stays > 20,000 microl, thus frank clinical bleeding is less common in HIT when compared to other conditions, where the platelet may fall below 10,000/ microl.

History

Heparin therapy

  • Occurs commonly after 5-10 days of initiation of heparin therapy. Onset of HIT after 2 weeks of heparin therapy is uncommon. Earlier onset of HIT is usually seen in patients who have been previously treated with heparin (1-3 months back) and have circulating HIT antibodies in them. In these patients the median time of platelet fall is less than 12 hours after the start of heparin administration
  • Delayed onset HIT:
    • Occurs after heparin has been withdrawn (median time of 14 days after heparin withdrawl)
    • High titer platelet-activating antibodies that have both increased heparin-dependent and heparin independent platelet activation
    • The phenomena is sometimes explained by the fact that unusually high antibody levels react with platelet-associated Platelet Factor 4 (PF4) bound to non-heparin glycosaminoglycans like chondroitin sulfate and not to heparin.
  • The incidence of delayed onset HIT are less compared to other forms of HIT.

Cardiac surgery

  • In cardiac surgery patients, decrease in the platelet count by > 50 % can occur within 3 days of surgery. This may be attributed to prolonged contact of platelets with the artificial surface and administration of large amount of unfractionated heparin (UFH). However, a diagnosis of HIT is more probable if a fall in the platelet counts ≥50 % is seen after 5-10 days of heparin therapy.

Symptoms

  • Presents with symptoms suggestive of arterial and venous thrombosis. The increased incidences of thrombosis may be attributed to:
    • Release of procoagulants by activated platelets
    • Release of platelet membranes that in turn activates coagulation pathways
    • HIT antibodies bind and activate endothelial cells resulting in release of tissue factor and thrombin

Venous thrombosis

Deep vein thrombosis (DVT)

  • (The classical symptoms of DVT include: Pain, redness and swelling of the affected area, dilation of the surface veins.

Pulmonary embolism

  • Three major clinical presentations can exist: difficulty in breathing with or without pleuritic chest pain and blood stained sputum, syncope (associated with massive pulmonary embolism). In the elderly, it may mimick as indolent pneumonia or heart failure. Pulmonary embolism should be suspected[1] in all patients who present with the following symptoms, without an alternative obvious cause.
  • Dyspnea (new or worsening)
  • Chest pain
  • Sustained Hypotension

Limb gangrene

  • Can be seen in both upper and lower extremities. However, lower extremities are commoner compared to upper.

Arterial thrombosis

It can present itself with one of these diseases like stroke, myocardial infarction, peripheral arterial occlusion, or end organ infarction (renal).

Skin necrosis

  • Redness of skin, purpura, bleeding from the area
  • Commonly seen in abdomen, distal extremities and nose.

Reference

  1. Agnelli G, Becattini C (2010). "Acute pulmonary embolism". N Engl J Med. 363 (3): 266–74. doi:10.1056/NEJMra0907731. PMID 20592294.

Template:WS Template:WH